Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, Patient Services Operations, Rare Endocrinology & Tumor
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Boston - MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Senior Director, External Expert Engagement Services” (Computer and Information Systems Managers) in DE: $215k–$215k, median $215k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
The Director, Patient Services Operations, Rare Endocrinology & RareTumor (RERT) plans, directs, supervises, and evaluates all aspects of the RERT Case Management team. As a second-line people leader, this individual ensures efficient, compliant, and patient-centered operations in accordance with Alexion policies, SOPs, work instructions, and values. The Director oversees support for patients throughout the treatment journey across injectable, oral, and infused therapies, while partnering with specialty pharmacies, vendors, and cross-functional stakeholders to optimize access, communication, and the patient experience. This individual uses sound judgment, data, critical thinking, and problem-solving skills to resolve issues, drive continuous improvement, and execute short- and long-term objectives aligned with business priorities. This position is based in Boston or New Haven You will be responsible for: • Leading the RERT Case Management team by setting direction, priorities, and performance standards; directing education and training; inspiring the team through change and new launches; cultivating an inclusive, high-performing culture; recognizing excellence; developing leaders; and strengthening engagement and retention. • Serving as a key member of the RERT Patient Services Leadership Team and representing Patient Services Operations in leadership forums, portfolio meetings, and cross-functional RERT activities, ensuring operational perspectives are incorporated into strategy, planning, and execution. • Directing RERT Case Management operations and workflow development across injectable, oral, and infused therapies, partnering cross-functionally to define and optimize processes for new products and indications, increased patient volume, evolving payer requirements, and other changes in market dynamics. • Leading operational readiness for new products, indications, and emerging business needs by translating plans into clear roles, workflows, timelines, training requirements, vendor readiness activities, and implementation milestones. • Owning operational oversight and governance of specialty pharmacy partners and other external vendors, including performance management, service-level expectations, key performance indicators, quality standards, business reviews, issue escalation, root-cause analysis, corrective actions, business continuity planning, and continuous improvement to enhance service quality, efficiency, and the patient experience. • Partnering with specialty pharmacies, field leadership, and other internal and external stakeholders to support patient access and coordinate enrollment, benefits investigation, prior authorization, appeals, prescription fulfillment, therapy initiation, site-of-care needs, refill support, and ongoing case management, as applicable. • Driving operational efficiency and improving the patient and provider experience by using data, stakeholder feedback, process mapping, and root-cause analysis to simplify workflows, improve communication, reduce delays and avoidable handoffs, and identify opportunities for continuous improvement. • Establishing and monitoring operational performance measures for the Case Management team and supporting vendors, using trends and insights to identify risks, inform business decisions, improve service delivery, and support timely issue resolution. • Ensuring compliance, quality, and operational control by maintaining adherence to company policies, SOPs, work instructions, internal controls, compliance requirements, privacy standards, quality expectations, and pharmacovigilance obligations. • Leading or designating a representative for cross-functional initiatives and serve as the primary operational point of contact for business partners regarding RERT